PPARα has neuroprotective effects in several disease models including stroke, Alzheimer's disease, Parkinson's disease, traumatic brain injury, diabetic peripheral neuropathy, and retinopathy [8–12]. The gene discussed is PPARA; the disease is early-onset autosomal dominant Alzheimer disease.